HTG Announces New Patent for Its Technology Issued in Japan
Patent covers nuclease protection methods for detection of nucleotide variants TUCSON, Ariz. , April 03, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the issuance of
- Category:
- Press Releases